{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:40:05Z","timestamp":1762530005150,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Cancer Center"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.adro.2019.08.014","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T19:16:52Z","timestamp":1568402212000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["How Much Was the Elective Lymph Node Region Covered in Involved-Field Radiation Therapy for Locally Advanced Pancreatic Cancer? Evaluation of Overlap Between Gross Target Volume and Celiac Artery\u2013Superior Mesenteric Artery Lymph Node Regions"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-3676","authenticated-orcid":false,"given":"Rei","family":"Umezawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Jingu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Itami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2019.08.014_bib1","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1200\/JCO.2005.23.911","article-title":"Locally advanced pancreatic cancer","volume":"23","author":"Willett","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2019.08.014_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2007.12.020","article-title":"Borderline resectable pancreatic cancer: The importance of this emerging stage of disease","volume":"206","author":"Katz","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.adro.2019.08.014_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","article-title":"Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators","volume":"4","author":"Sohn","year":"2000","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.adro.2019.08.014_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.surg.2005.08.004","article-title":"Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail","volume":"139","author":"Shimada","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.adro.2019.08.014_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<583::AID-CNCR8>3.0.CO;2-J","article-title":"Analysis of paraaortic lymph node involvement in pancreatic carcinoma: A significant indication for surgery?","volume":"85","author":"Kayahara","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2019.08.014_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11605-008-0762-x","article-title":"Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: Effect of number of metastatic lymph nodes and lymph node ratio","volume":"13","author":"Asiyanbola","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.adro.2019.08.014_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0b013e31823d813c","article-title":"Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer","volume":"255","author":"Takahashi","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2019.08.014_bib8","first-page":"3755","article-title":"Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer","volume":"26","author":"Ito","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2019.08.014_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijrobp.2012.01.022","article-title":"Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer","volume":"83","author":"Goodman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2004.12.018","article-title":"Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis","volume":"62","author":"Brunner","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijrobp.2006.12.053","article-title":"Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer","volume":"68","author":"Murphy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2012.03.059","article-title":"A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer","volume":"85","author":"Ikeda","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib13","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2019.08.014_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ijrobp.2013.09.005","article-title":"Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: A new approach to adjuvant radiation field design","volume":"87","author":"Dholakia","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3748\/wjg.v17.i9.1126","article-title":"CT diagnosis of recurrence after pancreatic cancer: Is there a pattern?","volume":"17","author":"Heye","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.adro.2019.08.014_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2009.05.039","volume":"77","author":"Kimura","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijrobp.2008.07.070","article-title":"Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: Dose-response relationship","volume":"73","author":"Kepka","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02924114","article-title":"Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer","volume":"10","author":"Nagakawa","year":"1991","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.adro.2019.08.014_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1748-717X-7-86","article-title":"Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer","volume":"7","author":"Caravatta","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2019.08.014_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MPA.0b013e31818166e6","article-title":"Nerve plexus invasion in pancreatic cancer: Spread patterns on histopathologic and embryological analyses","volume":"37","author":"Makino","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.adro.2019.08.014_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2214\/AJR.09.3285","article-title":"Pathways of extrapancreatic perineural invasion by pancreatic adenocarcinoma: Evaluation with 3D volume-rendered MDCT imaging","volume":"194","author":"Deshmukh","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.adro.2019.08.014_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318065bfe6","article-title":"Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact","volume":"31","author":"Mitsunaga","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.adro.2019.08.014_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0b013e31824104c5","article-title":"Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"36","author":"Chatterjee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.adro.2019.08.014_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","article-title":"Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation","volume":"94","author":"Krishnan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.adro.2017.02.004","article-title":"Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC","volume":"2","author":"Colbert","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2019.08.014_bib26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ijrobp.2012.02.051","article-title":"A phase I\/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer","volume":"84","author":"Ben-Josef","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2014.06.066","article-title":"Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: Outcomes and toxicity","volume":"90","author":"Pollom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib28","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/j.ijrobp.2011.04.045","article-title":"Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer","volume":"81","author":"Mahadevan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.08.014_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-5-28","article-title":"Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: A pooled analysis of clinical evidence","volume":"5","author":"Sun","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2019.08.014_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02307820","article-title":"An anatomic study of the peripancreatic lymphatics","volume":"10","author":"Deki","year":"1988","journal-title":"Surg Radiol Anat"},{"key":"10.1016\/j.adro.2019.08.014_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/mpa.0b013e3180619677","article-title":"The nature of neural invasion by pancreatic cancer","volume":"35","author":"Kayahara","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.adro.2019.08.014_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clon.2014.01.003","article-title":"Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer","volume":"26","author":"Youl","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2019.08.014_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/SLA.0000000000001837","article-title":"Does size matter in pancreatic cancer?: Reappraisal of tumour dimension as a predictor of outcome beyond the TNM","volume":"266","author":"Marchegiani","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2019.08.014_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000104241","article-title":"Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer","volume":"7","author":"Matsumoto","year":"2007","journal-title":"Pancreatology"},{"key":"10.1016\/j.adro.2019.08.014_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2013.04.010","article-title":"A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy","volume":"107","author":"Fokas","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.08.014_bib36","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.prro.2018.06.006","article-title":"Incidence and patterns of locoregional failure after stereotactic body radiation therapy for pancreatic adenocarcinoma","volume":"9","author":"Baine","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2019.08.014_bib37","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2019.08.014_bib38","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2019.08.014_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.mpa.0000194607.16982.d7","article-title":"Distribution of lymphatic vessels in the neural plexuses surrounding the superior mesenteric artery","volume":"32","author":"Jin","year":"2006","journal-title":"Pancreas"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109419301290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109419301290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:37:01Z","timestamp":1762529821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109419301290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2452109419301290"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2019.08.014","relation":{},"ISSN":["2452-1094"],"issn-type":[{"type":"print","value":"2452-1094"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How Much Was the Elective Lymph Node Region Covered in Involved-Field Radiation Therapy for Locally Advanced Pancreatic Cancer? Evaluation of Overlap Between Gross Target Volume and Celiac Artery\u2013Superior Mesenteric Artery Lymph Node Regions","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2019.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}